Great Point Partners Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Great Point Partners Llc disclosed 35 stock positions valued at approximately $424.45M as of quarter-end June 30, 2026. The largest holdings include VOR BIOPHARMA INC, ABIVAX SA, and VERA THERAPEUTICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 35
- Portfolio Value
- $424.45M
Holdings by Sector
Great Point Partners Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| VOR BIOPHARMA INC | VOR | Healthcare | 7.37% | 1,700,000 | -50,000 | -2.86% | $31,297,000 |
| ABIVAX SA | ABVX | Healthcare | 6.41% | 204,314 | +204,314 | +100.00% | $27,226,884 |
| VERA THERAPEUTICS INC | VERA | Healthcare | 6.07% | 600,836 | +401,488 | +201.40% | $25,781,873 |
| ZURA BIO LTD | ZURA | Healthcare | 5.86% | 4,215,930 | - | - | $24,873,987 |
| ALUMIS INC | ALMS | Healthcare | 5.68% | 856,061 | - | - | $24,089,557 |
| SOL-GEL TECHNOLOGIES LTD | SLGL | Healthcare | 4.79% | 274,363 | - | - | $20,341,273 |
| DEFINIUM THERAPEUTICS INC | DFTX | Healthcare | 4.71% | 425,000 | +425,000 | +100.00% | $19,992,000 |
| ANNEXON INC | ANNX | Healthcare | 4.71% | 3,500,000 | +1,000,000 | +40.00% | $19,985,000 |
| ORUKA THERAPEUTICS INC | ORKA | Healthcare | 4.11% | 183,330 | - | - | $17,447,516 |
| MOONLAKE IMMUNOTHERAPEUTICS | MLTX | Healthcare | 3.93% | 855,813 | +355,813 | +71.16% | $16,662,679 |
| SAGIMET BIOSCIENCES INC | SGMT | Healthcare | 3.70% | 2,029,933 | +2,029,933 | +100.00% | $15,691,382 |
| CONTINEUM THERAPEUTICS INC | CTNM | Healthcare | 3.56% | 921,481 | +121,283 | +15.16% | $15,103,074 |
| IMMIX BIOPHARMA INC | IMMX | Healthcare | 3.10% | 1,277,642 | +927,642 | +265.04% | $13,172,489 |
| CLIMB BIO INC | ELYM | Other | 3.07% | 1,000,000 | -334,130 | -25.04% | $13,040,000 |
| AMYLYX PHARMACEUTICALS INC | AMLX | Healthcare | 2.96% | 700,000 | -1,050,000 | -60.00% | $12,572,000 |
| NEKTAR THERAPEUTICS | NKTR | Healthcare | 2.88% | 175,000 | -141,453 | -44.70% | $12,216,750 |
| NEUROGENE INC | NGNE | Healthcare | 2.61% | 352,180 | -147,820 | -29.56% | $11,076,061 |
| LB PHARMACEUTICALS INC | LBRX | Healthcare | 2.43% | 317,221 | +17,221 | +5.74% | $10,295,408 |
| OPUS GENETICS INC | OCUP | Other | 1.91% | 1,970,187 | +1,645,847 | +507.44% | $8,097,469 |
| EUPRAXIA PHARMACEUTICALS INC | EPRX | Healthcare | 1.87% | 1,200,000 | - | - | $7,932,000 |
| BRIGHT MINDS BIOSCIENCES INC | DRUG | Healthcare | 1.81% | 109,603 | -110,397 | -50.18% | $7,694,131 |
| INFLARX NV | IFRX | Healthcare | 1.61% | 3,046,557 | +3,046,557 | +100.00% | $6,824,288 |
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 1.37% | 842,106 | - | - | $5,827,374 |
| CULLINAN THERAPEUTICS INC | CGEM | Healthcare | 1.29% | 300,000 | - | - | $5,463,000 |
| ALTIMMUNE INC | ALT | Healthcare | 1.25% | 1,741,232 | +1,741,232 | +100.00% | $5,293,345 |
| REZOLUTE INC | RZLT | Healthcare | 1.17% | 951,809 | - | - | $4,949,407 |
| SILENCE THERAPEUTICS PLC | SLN | Healthcare | 1.16% | 450,000 | -570,489 | -55.90% | $4,941,000 |
| PALISADE BIO INC | PALI | Healthcare | 1.13% | 2,284,819 | -1,120,938 | -32.91% | $4,775,272 |
| EVOMMUNE INC | EVMN | Healthcare | 1.02% | 325,000 | - | - | $4,319,250 |
| SCYNEXIS INC | SCYX | Healthcare | 0.91% | 944,292 | -6,610,055 | -87.50% | $3,843,268 |
Showing 30 of 35 holdings in the latest reporting period.
Great Point Partners Llc Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | ABVX | Abivax SA | CALL | 400,000 | $53,304,000 |
| Q2 2026 | IBRX | ImmunityBio, Inc. | PUT | 3,000,800 | $26,272,004 |
| Q2 2026 | RARE | Ultragenyx Pharmaceutical Inc. | PUT | 600,000 | $20,034,000 |
| Q2 2026 | GALT | Galectin Therapeutics Inc. | CALL | 800,000 | $3,712,000 |
| Q2 2026 | AVXL | Anavex Life Sciences Corp. | CALL | 521,300 | $1,350,167 |
Showing 5 of 5 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.